Reneo Pharmaceuticals Inc (RPHM)
1.66
-0.06
(-3.49%)
USD |
NASDAQ |
May 31, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
Reneo Pharmaceuticals Free Cash Flow: -75.65M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -75.65M |
| December 31, 2023 | -63.90M |
| September 30, 2023 | -59.99M |
| June 30, 2023 | -52.02M |
| March 31, 2023 | -47.88M |
| December 31, 2022 | -47.71M |
| September 30, 2022 | -41.96M |
| Date | Value |
|---|---|
| June 30, 2022 | -40.88M |
| March 31, 2022 | -38.61M |
| December 31, 2021 | -38.18M |
| September 30, 2021 | -33.50M |
| June 30, 2021 | -29.50M |
| March 31, 2021 | -22.73M |
| December 31, 2020 | -18.56M |
Free Cash Flow Range, Past 5 Years
-75.65M
Minimum
Mar 2024
-18.56M
Maximum
Dec 2020
-43.65M
Average
-41.42M
Median
Free Cash Flow Benchmarks
| Mirum Pharmaceuticals Inc | -42.04M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
| Theriva Biologics Inc | -18.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.01M |
| Cash from Investing (Quarterly) | 13.76M |
| Free Cash Flow Per Share (Quarterly) | -0.6288 |
| Free Cash Flow Yield | -139.2% |